113 related articles for article (PubMed ID: 6122452)
1. The binding characteristics of some adrenergic beta-receptor antagonists to human serum proteins.
Lemaire M; Tillement JP
Biochem Pharmacol; 1982 Feb; 31(3):359-65. PubMed ID: 6122452
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective binding of beta-blockers to purified rat alpha 1-acid glycoprotein.
Murai-Kushiya M; Okada S; Kimura T; Hasegawa R
J Pharm Pharmacol; 1993 Mar; 45(3):225-8. PubMed ID: 8097783
[TBL] [Abstract][Full Text] [Related]
3. Binding of beta-adrenoceptor blocking drugs to human serum albumin, to alpha 1-acid glycoprotein and to human serum.
Belpaire FM; Bogaert MG; Rosseneu M
Eur J Clin Pharmacol; 1982; 22(3):253-6. PubMed ID: 6125395
[TBL] [Abstract][Full Text] [Related]
4. Prazosin binding to human alpha 1-acid glycoprotein (orosomucoid), human serum albumin, and human serum. Further characterization of the 'single drug binding site' of orosomucoid.
Brunner F; Müller WE
J Pharm Pharmacol; 1985 May; 37(5):305-9. PubMed ID: 2862237
[TBL] [Abstract][Full Text] [Related]
5. Separation of the enantiomers of beta-receptor blocking agents and other cationic drugs using a CHIRAL-AGP column. Binding properties and characterization of immobilized alpha 1-acid glycoprotein.
Enquist M; Hermansson J
J Chromatogr; 1990 Nov; 519(2):285-98. PubMed ID: 1979791
[TBL] [Abstract][Full Text] [Related]
6. Nadolol binding to human serum proteins.
Patel L; Johnson A; Turner P
J Pharm Pharmacol; 1984 Jun; 36(6):414-5. PubMed ID: 6146679
[TBL] [Abstract][Full Text] [Related]
7. Contribution of alpha 1-acid glycoprotein to plasma protein binding of some basic antimicrobials in pigs.
Son DS; Hariya S; Shimoda M; Kokue E
J Vet Pharmacol Ther; 1996 Jun; 19(3):176-83. PubMed ID: 8803875
[TBL] [Abstract][Full Text] [Related]
8. Buffer and pH effects on propranolol binding by human albumin and alpha 1-acid glycoprotein.
Ravis WR; Parsons DL; Wang SJ
J Pharm Pharmacol; 1988 Jul; 40(7):459-63. PubMed ID: 2904983
[TBL] [Abstract][Full Text] [Related]
9. Using capillary electrophoresis/frontal analysis to screen drugs interacting with human serum proteins.
McDonnell PA; Caldwell GW; Masucci JA
Electrophoresis; 1998 Mar; 19(3):448-54. PubMed ID: 9551800
[TBL] [Abstract][Full Text] [Related]
10. Binding of oxprenolol and propranolol to serum, albumin and alpha 1-acid glycoprotein in man and other species.
Belpaire FM; Braeckman RA; Bogaert MG
Biochem Pharmacol; 1984 Jul; 33(13):2065-9. PubMed ID: 6743355
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the contribution of alpha 1-acid glycoprotein to the serum binding of basic drugs using serum treated with sulphosalicylic acid and DEAE-cellulose.
Suzuki Y; Sugiyama Y; Sawada Y; Iga T; Hanano M
J Pharm Pharmacol; 1985 Oct; 37(10):712-7. PubMed ID: 2867139
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective binding of tertatolol and of 4-hydroxytertatolol to human plasma proteins.
Bastian G; Urien S; Brée F; Jolliet P; Rocher I; Crambes O; Tillement JP
Eur J Drug Metab Pharmacokinet; 1992; 17(3):233-6. PubMed ID: 1362702
[TBL] [Abstract][Full Text] [Related]
13. Differences in the serum protein binding of prazosin in man and rat.
Dale O; Nilsen OG
Biochem Pharmacol; 1984 Jun; 33(11):1719-24. PubMed ID: 6732841
[TBL] [Abstract][Full Text] [Related]
14. Effect of altered AGP plasma binding on heart rate changes by S(-)-propranolol in rats using mechanism-based estimations of in vivo receptor affinity (K(B,vivo)).
van Steeg TJ; Krekels EH; Freijer J; Danhof M; de Lange EC
J Pharm Sci; 2010 May; 99(5):2511-20. PubMed ID: 20020526
[TBL] [Abstract][Full Text] [Related]
15. Binding of thioridazine and thioridazine metabolites to serum proteins. An in vitro study.
Nyberg G; Mårtensson E
Naunyn Schmiedebergs Arch Pharmacol; 1982 Jun; 319(3):189-96. PubMed ID: 7110380
[TBL] [Abstract][Full Text] [Related]
16. Enantioselective retention of beta-blocking agents on human serum albumin and alpha 1-acid glycoprotein HPLC columns: relationships with different scales of lipophilicity.
Barbato F; Carpentiero C; Grumetto L; La Rotonda MI
Eur J Pharm Sci; 2009 Dec; 38(5):472-8. PubMed ID: 19778607
[TBL] [Abstract][Full Text] [Related]
17. Binding of bornaprolol to human serum proteins and blood cells.
Shastri RA; Barre J; Houin G; Hamberger C; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):351-6. PubMed ID: 3733286
[TBL] [Abstract][Full Text] [Related]
18. Effect of altered plasma protein binding on pharmacokinetics and pharmacodynamics of propranolol in rats after surgery: role of alpha-1-acid glycoprotein.
Yasuhara M; Fujiwara J; Kitade S; Katayama H; Okumura K; Hori R
J Pharmacol Exp Ther; 1985 Nov; 235(2):513-20. PubMed ID: 2997437
[TBL] [Abstract][Full Text] [Related]
19. Plasma protein binding and erythrocyte partitioning of nicardipine in vitro.
Urien S; Albengres E; Comte A; Kiechel JR; Tillement JP
J Cardiovasc Pharmacol; 1985; 7(5):891-8. PubMed ID: 2413297
[TBL] [Abstract][Full Text] [Related]
20. The effect of the plasticizers TBEP (tris-(2-butoxyethyl)-phosphate) and DEHP (di-(2-ethylhexyl)-phthalate) on beta-adrenergic ligand binding to alpha 1-acid glycoprotein and mononuclear leukocytes.
Sager G; Little C
Biochem Pharmacol; 1989 Aug; 38(15):2551-7. PubMed ID: 2547384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
